While PrEP can prevent HIV, it does not protect against other sexually transmitted infections or pregnancy. PrEP stand for pre-exposure prophylaxis. This means it prevents you from getting HIV by ...

PEP is a four-week course of drugs, taken once a day during that time. It is best to start PEP within 24 hours of exposure to HIV, but certainly within 72 hours. There are two drugs in PrEP. They are ...

A groundbreaking Phase 1 study suggests that once-yearly intramuscular lenacapavir could be a promising option for HIV PrEP.

At the moment, the greatest impact is on prevention, as only 11 of the 30 promoters who supported doctors in initiating PrEP for key population users in the VICITS clinics have been rehired. Therefore ...

The decision to reimburse APRETUDE through the NIHB Program will have a meaningful impact on HIV prevention efforts for eligible First Nations and Inuit people who are at-risk of HIV and could ...

The 1917 PrEP Clinic is available to provide Pre-Exposure Prophylaxis (PrEP) to HIV-negative individuals to reduce their risk of acquiring HIV. To make an appointment, please call Michael Fordham at ...

CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce that APRETUDE (cabotegravir ...

APRETUDE (cabotegravir extended-release injectable suspension) is the first and only long-acting injectable pre-exposure prophylaxis (PrEP) option proven superior to daily oral FTC/TDF in reducing ...

The decision to reimburse APRETUDE through the NIHB Program will have a meaningful impact on HIV prevention efforts for eligible First Nations and Inuit people who are at-risk of HIV and could benefit ...

Received positive feedback on New Drug Application submission via the 505(b)(2) pathway-Company leveraging existing human pharmacokinetic data ...